Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Cidara Therapeutics Inc (CDTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cidara Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
62.020 +0.020    +0.03%
20:53:52 - Real-time Cboe. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 278,451
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 60.550 - 63.495
Cidara Therapeutics Inc 62.020 +0.020 +0.03%

CDTX Overview

 
Cidara Therapeutics Inc stock price live, this page displays NASDAQ CDTX stock exchange data. View the CDTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cidara Therapeutics Inc real time stock price chart below.

What Is the Cidara Therapeutics Inc Stock Price Today?
The Cidara Therapeutics Inc stock price today is 62.020.

What Is the Stock Symbol for Cidara Therapeutics Inc?
The stock symbol for Cidara Therapeutics Inc is ""CDTX.""

What Stock Exchange Does Cidara Therapeutics Inc Trade On?
Cidara Therapeutics Inc is listed and trades on the NASDAQ stock exchange.

Is Cidara Therapeutics Inc a Good Stock to Buy?
Determining whether Cidara Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CDTX quote. (ISIN: US1717572069)
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close62
Day's Range60.55 - 63.495
RevenueN/A
Open62.99
52 wk Range10.14 - 66.945
EPS - 10.21
Volume278,451
Market Cap1.58B
Dividend (Yield)N/A (N/A)
Average Volume (3m)701,260
P/E Ratio - 6.05
Beta1.19
1-Year Change424.98%
Shares Outstanding25,358,051
Next Earnings DateN/A
What is your sentiment on Cidara Therapeutics Inc?
or
Vote to see community's results!

Cidara Therapeutics Inc News


Cidara Therapeutics Inc Analysis


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 15 Current
Dark Cloud Cover 15 Current
Doji Star Bearish 1H Current
Harami Bearish 1M Current
Harami Cross Bearish 1M Current
Completed Patterns
Dark Cloud Cover 5H 1 Aug 11, 2025 13:00
Three Outside Up 1M 2 Jun 25
Advance Block Bearish 1W 2 Jul 27, 2025

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  VFD PLC 12.10 12.50 12.10 -1.30 -9.70% 25.79M  
  Ellah Lakes 14.60 14.60 13.80 +1.32 +9.94% 32.33M 14:34:59  
  Aiico 3.85 3.85 3.80 +0.35 +10.00% 154.73M 14:34:59  
  Initiates 13.20 13.20 12.10 +1.20 +10.00% 9.58M 14:34:59  
  BUA Cement 168.60 168.60 168.60 0.00 0.00% 783.47K 14:34:59  
  Daarcomm 1.03 1.03 0.95 +0.06 +6.19% 12.00M 14:34:59  
  Access Holdings 27.70 27.70 27.50 +0.10 +0.36% 28.76M 14:34:59  
  Sterling Bank 8.250 8.450 8.050 -0.100 -1.20% 120.20M 14:34:59  
  Linkassure 2.26 2.26 2.08 +0.20 +9.71% 703.59M 14:34:59  
  Zenith Bank 74.00 74.65 73.85 -0.65 -0.87% 16.05M 14:34:59  

Cidara Therapeutics Inc Company Profile

IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

38

Equity Type

ORD

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CDTX Comments

Write your thoughts about Cidara Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email